Loading…
Nutex Health Inc. is projected to rise to $137.50 by 2027, a +15% move from its current price of $119.45. NUTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $114.45 | $119.38 | $124.52 | -0.06% |
| May 30 | $112.40 | $119.31 | $126.63 | -0.12% |
| May 31 | $110.84 | $119.23 | $128.26 | -0.18% |
| Jun 1 | $109.53 | $119.16 | $129.64 | -0.24% |
| Jun 2 | $108.38 | $119.09 | $130.86 | -0.30% |
| Jun 3 | $107.35 | $119.02 | $131.96 | -0.36% |
| Jun 4 | $106.40 | $118.95 | $132.98 | -0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $106.40 | $118.95 | $132.98 | -0.42% |
| Week 2 | $101.17 | $118.45 | $138.68 | -0.84% |
| Week 3 | $97.24 | $117.95 | $143.07 | -1.25% |
| Week 4 | $93.98 | $117.46 | $146.79 | -1.67% |
| Week 5 | $91.16 | $116.96 | $150.08 | -2.08% |
| Week 6 | $88.64 | $116.47 | $153.04 | -2.49% |
| Week 7 | $86.36 | $115.98 | $155.77 | -2.90% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate.
The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs.
The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
Nutex Health Inc. (NUTX) is a healthcare services and operations company with three segments: Hospital, Population Health Management, and Real Estate. The stock trades with a current price of $118.91 and a market capitalization of $818.26M, ranking 2676 by market size.
The forecasted path shows a rising trajectory over time, with the average price climbing from $118.91 in 2026 to $264.00 in 2030 and to $1,369.94 by 2050.
A major floor 35.2% below — a decisive break under it would weaken the trend.
The nearest floor, 14.8% below — buyers have tended to step in here.
The nearest ceiling, 23.2% above — a clean break opens room to run.
A major ceiling 40.8% above — clearing it would confirm fresh momentum.
Key NUTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NUTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $120.40 | Sell | $121.34 | Sell |
| MA 10 | $123.91 | Sell | $123.17 | Sell |
| MA 20 | $127.41 | Sell | $122.81 | Sell |
| MA 50 | $112.04 | Buy | $118.41 | Buy |
| MA 100 | $120.42 | Sell | $118.69 | Buy |
| MA 200 | $119.44 | Buy | $115.68 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.27 | Neutral |
| Stoch RSI (14) | 3.53 | Buy |
| CCI (20) | -75.89 | Neutral |
| Williams %R (14) | -96.79 | Info |
| MACD (12,26,9) | -2.11 | Sell |
| ROC (12) | -12.59 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 3.21 | Buy |
| TRIX (15) | 0.57 | Buy |
| Awesome (5,34) | 1.20 | Buy |
| Ultimate (7,14,28) | 36.63 | Neutral |
| Momentum (10) | -16.03 | Sell |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 118.83 | Buy |
| ADX (14) | 12.19 | Neutral |
| ATR (14) | 4.19 | Info |
The current sentiment is NEUTRAL with RSI(14) at 50, and the 50-day and 200-day simple moving averages sit at $110.81 and $119.11 respectively. These moving averages provide nearby support and resistance around the price, with a nearby setup consistent with a neutral stance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $87.01 | $119.45 | $164.70 | 0% | Neutral | |
| $103.31 | $137.50 | $196.79 | +15% | Neutral | |
| $114.02 | $158.67 | $238.98 | +33% | Bullish | |
| $168.88 | $244.11 | $382.58 | +104% | Bullish | |
| $185.36 | $277.24 | $449.24 | +132% | Bullish | |
| $181.09 | $279.57 | $466.30 | +134% | Bullish | |
| $198.17 | $315.21 | $539.49 | +164% | Bullish | |
| $187.61 | $307.03 | $537.87 | +157% | Bullish | |
| $238.69 | $401.46 | $718.45 | +236% | Bullish | |
| $317.65 | $548.63 | $1,001.35 | +359% | Bullish | |
| $381.43 | $746.36 | $1,478.12 | +525% | Bullish | |
| $695.21 | $1,544.90 | $3,437.38 | +11.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $87.01 | $119.45 | $141.02 | +0.00% |
| June 2026 | $96.53 | $114.71 | $140.55 | -3.97% |
| July 2026 | $93.91 | $113.08 | $141.40 | -1.42% |
| August 2026 | $97.31 | $118.40 | $150.36 | +4.70% |
| September 2026 | $96.84 | $118.84 | $152.82 | +0.37% |
| October 2026 | $93.33 | $115.45 | $150.16 | -2.85% |
| November 2026 | $95.75 | $119.27 | $156.66 | +3.31% |
| December 2026 | $99.07 | $124.23 | $164.70 | +4.16% |
Click any year to see its month-by-month NUTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NUTX to range from $87.01 to $164.70 through 2026. The $119.45 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The NUTX price prediction for 2027 points to an average of $137.50 (low $103.31, high $196.79) — a potential gain of +15% on today's $119.45. A consolidation phase looks the most probable path here.
In 2028, NUTX is projected to trade between $114.02 and $238.98, averaging $158.67 — a potential gain of +33% from today's $119.45. That is up +15% on the projected 2027 average. Momentum favours further upside here.
Nutex Health Inc.'s 2029 outlook centres on $244.11, within a $168.88 to $382.58 range. That is up +54% on the projected 2028 average. That marks a +104% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, NUTX could reach as high as $449.24, with a base case around $277.24 and support toward $185.36 — roughly +132% from $119.45. Momentum favours further upside here.
Expect NUTX to range from $181.09 to $466.30 through 2031. The $279.57 average target implies a +134% move from current prices. That is up +1% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The NUTX price prediction for 2032 points to an average of $315.21 (low $198.17, high $539.49) — a potential gain of +164% on today's $119.45. Momentum favours further upside here.
In 2033, NUTX is projected to trade between $187.61 and $537.87, averaging $307.03 — a potential gain of +157% from today's $119.45. That is -3% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
Nutex Health Inc.'s 2034 outlook centres on $401.46, within a $238.69 to $718.45 range. That is up +31% on the projected 2033 average. That marks a +236% change versus current levels. Momentum favours further upside here.
By 2035, NUTX could reach as high as $1,001.35, with a base case around $548.63 and support toward $317.65 — roughly +359% from $119.45. Buyers look set to stay in control over this stretch.
Expect NUTX to range from $381.43 to $1,478.12 through 2040. The $746.36 average target implies a +525% move from current prices. That is up +36% on the projected 2035 average. Momentum favours further upside here.
The NUTX price prediction for 2050 points to an average of $1,544.90 (low $695.21, high $3,437.38) — a potential gain of +11.9x on today's $119.45. Buyers look set to stay in control over this stretch.
Investing $1,000 in NUTX today (≈ 8.371704 NUTX) could be worth
$12,933.45
+$11,933.45 (+1193%) by 2050 · US Dollar
Based on the average projected NUTX price of $1,544.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NUTXwould be worth at today's price.
$1,000 invested in NUTX on May 27, 2025 (≈ 6.107616 NUTX) would be worth
$729.55
-$270.45 (-27.0%) today · 0.73× · US Dollar
Based on a NUTX entry price of $163.73 vs. today's $119.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $121.54 | $982.8 | -1.7% |
| 1 month ago | $110.79 | $1,078.17 | +7.8% |
| 3 months ago | $115.77 | $1,031.79 | +3.2% |
| 6 months ago | $115.11 | $1,037.7 | +3.8% |
| 1 year ago | $163.73 | $729.55 | -27.0% |
| All time (4.1y) ago | $6,000 | $19.91 | -98.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NUTX forecast.
Our base-case forecast reaches $240.00 around 2029.
Implied market cap at $240.00: $1.65B
The multi-year forecast shows a bullish trajectory with expanding price levels and strong upside potential. In 2026 the average price is $118.91, and by 2027 it rises to $132.48 with a ROI of 11.4; in 2028 the average is $153.27 with a ROI of 28.9; by 2029 the average reaches $234.47 (ROI 97.2). The 2030 forecast shows an average of $264.00 with a ROI of 122 and bullish sentiment, followed by 2031 at $265.18 (ROI 123) and 2032 at $294.70 (ROI 147.8).
The path continues higher to 2033 at $283.64 (ROI 138.5) and 2034 at $372.80 (ROI 213.5), then to 2035 at $506.95 (ROI 326.3). The long-range 2040 forecast shows an average of $678.48 (ROI 470.6) and a max of $1,364.40, while 2050 projects an average of $1,369.94 (ROI 1052.1) with a max of $3,102.08. The forecast remains bullish across these years, but always note that these are estimates, not guarantees.
Tap a question to reveal the answer.
2030: avg $264.00; min $174.47; max $432.42; ROI 122; sentiment BULLISH.
Forecasts show rising averages and bullish sentiment from 2027 onward, with 2027 avg $132.48, 2028 avg $153.27, 2029 avg $234.47, 2030 avg $264.00, 2040 avg $678.48, and 2050 avg $1,369.94. These are estimates, not guarantees, and near-term volatility remains a factor.
Yes. The 2040 max is $1,364.40 and the 2050 max is $3,102.08, indicating potential to surpass $1,000 in the longer term under the forecast.
Current price $118.91; market cap $818.26M.
Forecasts are estimates and not guarantees. The asset shows high volatility, with annualized volatility 80%.
Nutex Health Inc. Community Discussion
0Share your Nutex Health Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.